In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, ArriVent BioPharma Inc (NASDAQ: AVBP) closed at $20.12 down -2.90% from its previous closing price of $20.72. In other words, the price has decreased by -$2.90 from its previous closing price. On the day, 0.61 million shares were traded. AVBP stock price reached its highest trading level at $20.905 during the session, while it also had its lowest trading level at $20.03.
Ratios:
For a deeper understanding of ArriVent BioPharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.90 and its Current Ratio is at 14.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on December 10, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On November 25, 2025, Truist started tracking the stock assigning a Buy rating and target price of $43.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVBP now has a Market Capitalization of 830580992 and an Enterprise Value of 530370976.
Stock Price History:
The Beta on a monthly basis for AVBP is 1.00, which has changed by -0.26889533 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, AVBP has reached a high of $29.71, while it has fallen to a 52-week low of $15.47. The 50-Day Moving Average of the stock is -4.40%, while the 200-Day Moving Average is calculated to be -1.10%.
Shares Statistics:
For the past three months, AVBP has traded an average of 360.85K shares per day and 472880 over the past ten days. A total of 40.85M shares are outstanding, with a floating share count of 26.30M. Insiders hold about 36.30% of the company’s shares, while institutions hold 70.51% stake in the company. Shares short for AVBP as of 1765756800 were 6747370 with a Short Ratio of 18.70, compared to 1763078400 on 7169047. Therefore, it implies a Short% of Shares Outstanding of 6747370 and a Short% of Float of 21.72.
Earnings Estimates
As of right now, 11.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.92, with high estimates of -$0.77 and low estimates of -$1.05.
Analysts are recommending an EPS of between -$2.96 and -$4.82 for the fiscal current year, implying an average EPS of -$4.29. EPS for the following year is -$3.91, with 11.0 analysts recommending between -$3.12 and -$5.25.
